Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SUPERNUS PHARMACEUTICALS, INC. v. TWI PHARMACEUTICALS, INC. et al
Case Number:
1:15-cv-00369
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 01, 2019
TWi Must Pay Fees After Ignoring Court Warnings In IP Row
TWi Pharmaceuticals must foot part of Supernus Pharmaceuticals' legal bills after relying on a position that was "squarely at odds with the evidence presented" at a patent infringement trial, a New Jersey federal judge has ruled.
-
August 16, 2017
TWi Infringed Supernus Patents For Seizure Drug, Court Says
A New Jersey federal judge ruled Tuesday that Supernus Pharmaceuticals Inc.'s patents related to its anti-epileptic drug are valid and infringed by TWi Pharmaceuticals Inc. and its subsidiary, which had sought permission to market a generic version.